Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.96 - $13.59 $1,440 - $2,459
-181 Reduced 1.22%
14,624 $123,000
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $13 - $20
1 Added 0.01%
14,805 $213,000
Q4 2023

Feb 14, 2024

SELL
$14.18 - $22.31 $397 - $624
-28 Reduced 0.19%
14,804 $318,000
Q3 2023

Nov 14, 2023

BUY
$18.22 - $25.85 $54 - $77
3 Added 0.02%
14,832 $285,000
Q2 2023

Aug 14, 2023

SELL
$22.62 - $39.32 $407 - $707
-18 Reduced 0.12%
14,829 $376,000
Q1 2023

May 15, 2023

BUY
$30.17 - $41.11 $246,066 - $335,293
8,156 Added 121.9%
14,847 $536,000
Q4 2022

Feb 14, 2023

BUY
$36.43 - $49.4 $243,753 - $330,535
6,691 New
6,691 $264,000
Q3 2022

Nov 14, 2022

BUY
$40.66 - $53.03 $447 - $583
11 Added 0.16%
6,691 $312,000
Q2 2022

Aug 15, 2022

SELL
$40.85 - $77.67 $163 - $310
-4 Reduced 0.06%
6,680 $293,000
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $119 - $184
2 Added 0.03%
6,684 $483,000
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $272,476 - $407,655
3,361 Added 101.2%
6,682 $542,000
Q3 2021

Nov 16, 2021

BUY
$101.99 - $166.36 $338,708 - $552,481
3,321 New
3,321 $387,000
Q4 2018

Feb 06, 2019

SELL
$35.43 - $56.29 $44 Million - $69.9 Million
-1,241,720 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$44.22 - $75.47 $28.5 Million - $48.6 Million
-643,835 Reduced 34.15%
1,241,720 $70.8 Million
Q2 2018

Aug 10, 2018

SELL
$72.38 - $92.5 $10.4 Million - $13.3 Million
-143,265 Reduced 7.06%
1,885,555 $151 Million
Q1 2018

May 14, 2018

BUY
$69.46 - $88.57 $26.1 Million - $33.3 Million
376,264 Added 22.77%
2,028,820 $176 Million
Q4 2017

Feb 09, 2018

BUY
$65.94 - $93.31 $26.6 Million - $37.6 Million
403,189 Added 32.27%
1,652,556 $114 Million
Q3 2017

Nov 14, 2017

SELL
$80.87 - $91.08 $14 Million - $15.7 Million
-172,600 Reduced 12.14%
1,249,367 $0
Q2 2017

Aug 17, 2017

BUY
N/A
1,421,967
1,421,967 $106 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.